MedPath

Soy Formula Feedings in Healthy, Term Infants

Not Applicable
Completed
Conditions
Gastrointestinal Tolerance
Registration Number
NCT02456831
Lead Sponsor
Abbott Nutrition
Brief Summary

This study evaluates the GI tolerance and acceptability of soy formulas fed to healthy term infants with reported intolerance to a milk-based formula.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
115
Inclusion Criteria
  • Healthy infants believed by their parents and/or physicians to be experiencing symptoms of cow's milk formula intolerance and who had not previously consumed a soy-based formula (Intervention subjects).
  • Health infants reported to be tolerating a milk-based formula (Cohorts).
  • Infants considered full-term, 2 to 9 weeks of age with a birth-weight above the 5th percentile (NCHS).
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Stool Characteristics QuestionnaireChange from Baseline (Study Day 1) to Study Day 15

stool number, consistency, and color

Secondary Outcome Measures
NameTimeMethod
WeightChange from Baseline (Study Day 1) to Study Day 15

weight and weight gain

Formula IntakeChange from Baseline (Study Day 1) to Study Day 15

volume consumed

Gastrointestinal Tolerance QuestionnaireChange from Baseline (Study Day 1) to Study Day 15

Incidence of spit up and vomiting

Trial Locations

Locations (7)

Arkansas Children's Hospital

🇺🇸

Little Rock, Arkansas, United States

Dreyer Clinic

🇺🇸

Aurora, Illinois, United States

T&W Research

🇺🇸

Owensboro, Kentucky, United States

Park Nicollet Medical Foundation

🇺🇸

Minneapolis, Minnesota, United States

Clinical Studies, Inc

🇺🇸

Canton, Ohio, United States

Research Memphis

🇺🇸

Memphis, Tennessee, United States

Child Care Associates

🇺🇸

San Antonio, Texas, United States

Arkansas Children's Hospital
🇺🇸Little Rock, Arkansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.